Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

Elizabeth Ann Altman net worth and biography

Elizabeth Altman Biography and Net Worth

Director of Veradigm

Beth Altman has more than 25 years of experience in accounting, finance, management, business development, strategic planning and corporate governance at accounting firm KPMG. Most recently and until her retirement on September 2019, Ms. Altman served as an Office Managing Partner, where she successfully led a team of more than 260 professionals and 23 partners, providing an array of assurance, tax and advisory services to public and private companies across all industry sectors. Additionally, Beth served as the lead audit partner for numerous early-stage, middle-market and large global clients in the public and private markets, predominantly in the life sciences, consumer markets and technology sectors. Since October 2019, Beth has served on the board of directors and on the audit committee of CV Sciences, Inc., which trades on the OTC:QB Marketplace. Beth also served as a board member of the Corporate Directors Forum, a 501(c)(6) nonprofit organization focused on helping directors, and those who support them, build more effective boards through continuous learning and peer networking. She also held a leadership position in the San Diego Chapter of Women Corporate Directors, the world’s largest membership organization and community of today’s preeminent women leaders in business.

What is Elizabeth Ann Altman's net worth?: The estimated net worth of Elizabeth Ann Altman is at least $296,001.00 as of June 16th, 2023. Ms. Altman owns 31,158 shares of Veradigm stock worth more than $296,001 as of December 22nd. This net worth approximation does not reflect any other investments that Ms. Altman may own. Learn More about Elizabeth Ann Altman's net worth.
How do I contact Elizabeth Ann Altman?: The corporate mailing address for Ms. Altman and other Veradigm executives is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. Veradigm can also be reached via phone at (800) 334-8534 and via email at [email protected]. Learn More on Elizabeth Ann Altman's contact information.
Has Elizabeth Ann Altman been buying or selling shares of Veradigm?: Elizabeth Ann Altman has not been actively trading shares of Veradigm during the last ninety days. Most recently, Elizabeth Ann Altman sold 6,028 shares of the business's stock in a transaction on Friday, May 27th. The shares were sold at an average price of $16.75, for a transaction totalling $100,969.00. Following the completion of the sale, the director now directly owns 22,796 shares of the company's stock, valued at $381,833. Learn More on Elizabeth Ann Altman's trading history.
Who are Veradigm's active insiders?: Veradigm's insider roster includes Elizabeth Altman (Director), Paul Black (CEO), Greg Garrison (Director), Lisa Khorey (Insider), Michael Klayko (Director), and Richard Poulton (CFO). Learn More on Veradigm's active insiders.

Elizabeth Ann Altman Insider Trading History at Veradigm

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/27/2022	Sell	6,028	$16.75	$100,969.00	22,796
6/14/2021	Sell	11,600	$17.78	$206,248.00	28,824

Elizabeth Ann Altman Buying and Selling Activity at Veradigm

Veradigm Company Overview

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Today's Range

Now: $9.50

$9.50

$9.52

50 Day Range

MA: $9.98

$9.00

$11.30

2 Week Range

Now: $9.50

$5.01

$11.80

Volume

160,761 shs

Average Volume

1,475,412 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

The #1 Coin for November 2024

From Crypto 101 Media | Ad